E.M. Heuts

van der Venne, W. B. W., Goeree, K. S., Wederfoort, J. L. M., Hommes, J. E., van Kuijk, S. M. J., Heuts, E. M., Piatkowski de Grzymala, A. A., Mouës, C. M., & BREAST II Trial Investigators (2026). Results from the Multicenter Nonrandomized BREAST-II Trial for Total Breast Reconstruction Solely Using Autologous Fat Transfer: 1-Year Follow-Up. Plastic and Reconstructive Surgery, 158(4), 567e-577e. https://doi.org/10.1097/PRS.0000000000012742

Spoor, J., Mureau, M. A. M., de Jong, D., Tissier, R. L. M., Vis, M., Rakhorst, H., Hommes, J., de Boer, M., Oldenburg, H. S. A., Heuts, E. M., Vissers, Y. L. J., Dassen, A. E., Evers, D. J., Koppert, L. B., Zaal, L. H., van der Hulst, R. R. W. J., Vrancken Peeters, M.-J. T. F. D., Bleiker, E. M. A., & van Leeuwen, F. E. (2026). Risk of autoimmune and rheumatic diseases in breast cancer patients with silicone breast implants. Journal of the National Cancer Institute, 118(10), 1846-1856. https://doi.org/10.1093/jnci/djag115

Ding, N., Geurts, S. M. E., Hermans, K. E. P. E., Vriens, I. J. H., Visserman, R., Kooreman, L. F. S., Peters, N. A. J. B., Heuts, E. M., Verloop, J., Voogd, A. C., & Tjan-Heijnen, V. C. G. (2026). Treatment and survival of de novo HER2-positive metastatic breast cancer across regional cancer networks in the Netherlands: a cohort study. ESMO Real-World Data and Digital Oncology, 13(C), Article 100722. https://doi.org/10.1016/j.esmorw.2026.100722

Smeins, N. N. P. M., van Rooij, J. A. F., Heuts, E. M., Houwers, J. B., Nelemans, P. J., Tuinder, S. M. H., & van Nijnatten, T. J. A. (2026). Detection of residual fibroglandular tissue on breast MRI and associated factors in women treated with mastectomy and DIEP flap breast reconstruction. Insights into Imaging, 17(1), Article 208. https://doi.org/10.1186/s13244-026-02382-6

van der Venne, W. B. W., Smeins, N. N. P. M., Kuijlaars, Z. M. A., Van Kuijk, S. M. J., Rijkx, M. E. P., Bernardi, E., Houwers, J. B., Heuts, E. M., Van der Hulst, R. R. W. J., Piatkowski, A., & EVE trial investigators (2026). External vacuum expansion in autologous fat transfer as total breast reconstruction: Is it worth it? The interim analysis of the multicentre randomised controlled EVE trial. Journal of Plastic Reconstructive and Aesthetic Surgery, 119, 85-96. https://doi.org/10.1016/j.bjps.2026.05.072

Kuijlaars, Z. M. A., Smeins, N. N. P. M., Beugels, J., Heuts, E. M., van Nijnatten, T. J. A., van der Hulst, R. R. W. J., & Piatkowski, A. A. (2026). Autologous fat transfer for complete breast reconstruction in irradiated breast cancer patients: A systematic review. Journal of Plastic Reconstructive and Aesthetic Surgery, 118, 346-360. https://doi.org/10.1016/j.bjps.2026.05.048

Smeins, N. N. P. M., Kuijlaars, Z. M. A., Perez Rodrigo, S., Heuts, E. M., Piatkowski, A., & van Nijnatten, T. J. A. (2026). A review of radiological characteristics and patterns of fat necrosis after different autologous breast surgery techniques. Insights into Imaging, 17(1), Article 168. https://doi.org/10.1186/s13244-026-02330-4

van der Venne, W. B. W., Choudhury, I., de Wit, T., Heuts, E. M., van der Hulst, R. R. W. J., & Piatkowski, A. A. (2026). Eight Women With Autologous Fat Transfer and Deep Inferior Epigastric Perforator Flap Breast Reconstruction: Which Do They Prefer, and Why? Plastic and Reconstructive Surgery - Global Open, 14(4), Article e7650. https://doi.org/10.1097/GOX.0000000000007650

van der Venne, W. B. W., Michiels, R., van Kuijk, S. M. J., Tjan-Heijnen, V. C. G., van der Hulst, R. R. W. J., Heuts, E. M., Piatkowski, A., BREAST II Trial Investigators, & BREAST-trial Investigators (2026). Establishing oncological safety of autologous fat transfer for total breast reconstruction: Results from the multicentre BREAST-I and BREAST-II trials. European Journal of Surgical Oncology, 52(3), Article 111417. https://doi.org/10.1016/j.ejso.2026.111417

Berben, J. A., Heuts, E. M., de Grzymala, A. A. P., Misere, R. M., Garcia, E. B. G., van Kuijk, S. M. J., van der Hulst, R. R. W. J., & HEBON (2026). Patient satisfaction after breast reconstruction in a high-risk breast cancer population. JPRAS Open, 48, 193-204. https://doi.org/10.1016/j.jpra.2025.11.014